Prosaptide TX14(A)(196391-82-9)
- Name: Prosaptide TX14(A)
- Synonyms:Prosaptide TX14(A);THR-D-ALA-LEU-ILE-ASP-ASN-ASN-ALA-THR-GLU-GLU-ILE-LEU-TYR;L-Tyrosine, L-threonyl-D-alanyl-L-leucyl-L-isoleucyl-L-α-aspartyl-L-asparaginyl-L-asparaginyl-L-alanyl-L-threonyl-L-α-glutamyl-L-α-glutamyl-L-isoleucyl-L-leucyl-;Prosaptide TX14(A) TFA salt
- Molecular Formula:C69H110N16O26
- Molecular Weight:1579.73
- CAS Registry Number:196391-82-9
- EINECS:
- Melting Point:1954.9±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 1962928-28-4/LCB 03-0110 dihydrochloride (LCB03-0110)
- 1962929-90-3/4-[4-Bromo-2-(hydroxymethyl)phenoxy]-benzonitrile
- 1962931-71-0/3-Bromo-4-[2-fluoro-4-[[4-oxo-2-[[2-(pyridin-2-yl)ethyl]amino]-1,3-thiazol-5-(4H)ylidene]methyl]phenoxy]benzonitrile
- 1962973-02-9/Methyl 6-(2-hydroxy-2-Methylpropyl)nicotinate
- 196297-83-3/3-Dimethoxytrityloxy-2-(3-(fluorenylmethoxycarbonylamino)propanamido)propyl-1-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite
- 1962979-23-2/3,5-bis(difluoromethyl)-4-iodo-1H-pyrazole
- 196302-37-1/Naphthalene, 8-bromo-1,2-dihydro-5-methoxy-
- 196302-53-1/1,3-Dioxane, 2-[3-(3-bromo-2,5-dimethoxyphenyl)propyl]-
- 196302-54-2/Naphthalene, 2-bromo-7,8-dihydro-1,4-dimethoxy-
- 196302-61-1/β-D-Glucopyranoside, (3β,12β,23E)-20-(β-D-glucopyranosyloxy)-12-hydroxydammara-23,25-dien-3-yl 2-O-β-D-glucopyranosyl-
- 196303-99-8/1H-Imidazole, 4-ethyl-1-methyl-
- 196308-41-5/Prucalopride Impurity D
- 196309-10-1/Iomeprol Impurity 1
- 196309-13-4/1,4-Oxazino[4,3,2-de][1,4]benzoxazine-8,10-dicarboxamide, N8,N10-bis(2,3-dihydroxypropyl)-2,3,5,6-tetrahydro-9-iodo-3-oxo-
- 196314-60-0/Acetamide, 2-cyano-N-(4,6-dimethyl-2-pyridinyl)-
- 1963448-86-3/4-Chloro-5-fluoro-2-[3-(trifluoromethyl)phenyl]phenol
- 1963587-95-2/2-(2,5-dichlorophenyl)-4-methyl-1,3-thiazole-5-carboxylic acid
- 196391-40-9/methyl 2-(1H-1,3-benzodiazol-2-ylsulfanyl)propanoate
- 196391-55-6/4-Pyridinecarboxylic acid, 2-[2-(1H-benzimidazol-2-ylthio)-1-oxopropyl]hydrazide
- 196391-82-9/Prosaptide TX14(A)
- 196401-21-5/3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[4-[2,2,2-trifluoro-1-[(3-Methyl-1-oxobutyl)aMino]-1-(trifluoroMethyl)ethyl]-1-piperazinyl]-
- 1964432-62-9/4-[(E)-[(4-Nitrophenyl)methylene]amino]benzenesulfonamide
- 1964450-27-8/2-[1-[4-(chloromethyl)phenyl]ethyl]-4,6,8-tris[2-[4-(chloromethyl)phenyl]ethyl]-2,4,6,8-tetramethyl cyclotetrasiloxane
- 1964475-99-7/1-Piperazinecarboxylic acid, 4-(5-bromo-2-thienyl)-, 1,1-dimethylethyl ester
- 1964490-26-3/Isoquino[3,2-c][1,4]benzodiazepin-14(6aH)-one, 7,12-dihydro-3-hydroxy-2-methoxy-, (6aS)-
- 1964490-60-5/Allyl (6aS)-3,6-dihydroxy-2-methoxy-14-oxo-6,6a,7,12-tetrahydrobenzo[5,6][1,4]diazepino[1,2-b]isoquinoline-5(14H)-carboxylate
- 1964490-63-8/1,7-Naphthyridine-6-carboxylic acid, 5,6,7,8-tetrahydro-
- 1964503-38-5/Azido-PEG3-phosphonic acid
- 1964503-39-6/Carboxy-PEG4-phosphonic acid ethyl ester
- 1964506-29-3/ODN 20844